baber/WOPTO huggingface dataset:
Patent AU-2020281050-A1 (AU)
Title: A furniture leg
Inventor: UKMAR ROBERT CARLO
IPC: A47B9/20
Filed: 2020-12-02
Abstract: A telescopically adjustable table leg (5) is disclosed. The leg has an outer hollow 
sleeve (6) whin which an inner leg (7) is able to slide. The sleeve has an inwardly 
directed protrusion (16). The inner leg has a longitudinally extending groove (10) 
from which a series of regularly spaced apart recesses (11) extend. Opposite each 
recess (11) is a corresponding bump projection (13). The inner leg is rotated in an arc 
to locate, or remove, the protrusion from a recess. With the protrusion located in a 
recess, the location of the inner leg is set. With the protrusion removed from a recess, 
the inner leg is free to slide within the outer leg to adjust the location of the inner leg.  
During sliding when the protrusion hits a bump projection, this indicates that the 
location of a recess has been reached.  
'20AU7 All 1
3/3 
LC 
Lnn
Patent AU-2020282272-A1 (AU)
Title: Techniques to set focus in camera in a mixed-reality environment with hand gesture interaction
Inventor: LEI MARIA CHENG
IPC: H04N5/232
Filed: 2020-04-24
Abstract: An adjustable-focus PV (picture/video) camera in a mixed-reality head-mounted display (HMD) device operates with an auto-focus subsystem that is configured to be triggered based on location and motion of a user's hands to reduce the occurrence of auto-focus hunting during camera operations. The HMD device is equipped with a depth sensor that is configured to capture depth data from the surrounding physical environment to detect and track the user's hand location, movements, and gestures in three-dimensions. The hand tracking data from the depth sensor may be assessed to determine hand characteristics - such as which of the user's hands or part of a hand is detected, its size, motion, speed, etc. - within a particular region of interest (ROI) in the field of view of the PV camera. The auto-focus subsystem uses the assessed hand characteristics as an input to control auto-focus of the PV camera to reduce auto-focus hunting occurrences.
Patent AU-2020284596-A1 (AU)
Title: Manufacturing a flowcell with a planar waveguide
Inventor: YUAN DAJUN
IPC: B01L3/00
Filed: 2020-05-28
Abstract: Provided in one example is a method of manufacturing a flowcell that includes: forming a core layer, the core layer disposed between a substrate and a nanowell layer, the nanowell layer having nanowells to receive a sample, the core layer having a higher refractive index than the substrate and the nanowell layer; and forming a grating to couple light to the core layer.
Patent AU-2020337499-A1 (AU)
Title: Method and measuring vehicle for determining an actual position of a track
Inventor: AUER FLORIAN
IPC: B61L23/04
Filed: 2020-07-31
Abstract: The invention relates to a method for determining an actual position of a track (5) by means of a measuring vehicle (1) which can be moved on the track, in which, by means of a contactless detection system (8) arranged on the measuring vehicle, reference points (A, B, C) positioned in a lateral environment of the track are automatically detected and the actual distance (H, V) of each reference point from the track is determined. A three-dimensional trajectory (15) of the track is detected by means of an inertial measuring system (13) arranged on the measuring vehicle, and by means of a computer unit (22) the trajectory is divided into trajectory sections (15 AB,15
Patent AU-2020349599-A1 (AU)
Title: Antiperspirant compositions
Inventor: EVANS RICHARD LIVESEY
IPC: A61K8/41
Filed: 2020-09-17
Abstract: Natural antiperspirant compositions comprising benzaldehyde, honokiol or capsaicin and their method of use.
Patent AU-2020351238-A1 (AU)
Title: Reusable container for dispensing product in stick form
Inventor: LESLIE KERRI
IPC: B65D83/00
Filed: 2020-09-19
Abstract: The reusable container includes a housing assembly and an insert assembly. Each component of the housing assembly is designed to be reused, and each component of the insert assembly is designed to be reused, recycled, or composted, depending on the materials employed for construction. All reusable components of the container are preferably constructed of non- reactive, durable materials that are not susceptible, or at least resistant, to rust, corrosion, etc. Example materials for the reusable components include stainless steel, aluminum, carbon fiber, various types of polymers, and silicone. The container is designed to allow simple and complete assembly and disassembly. Thus, all reusable parts may be cleaned, replaced, or repaired, as needed, and all recyclable or compostable parts may be separated and cleaned in preparation for recycling or composting.
Patent AU-2020374961-A1 (AU)
Title: Methods of treating cancer in biomarker-identified patients with inhibitors of cyclin-dependent kinase 7 (CDK7)
Inventor: HODGSON J GRAEME
IPC: A61K31/519
Filed: 2020-10-29
Abstract: The present invention relates to methods of identifying patients suffering from various types of cancer who are more likely to respond to treatment with a CDK7 inhibitor described herein, or a pharmaceutically acceptable salt thereof, either when administered or used alone or in combination with a second therapeutic agent (e.g., another anti-cancer therapy). Patients are identified based on one or more features (e.g., gene copy number or expression level) of certain biomarkers (e.g., RBI or another member of the E2F pathway). In addition, the present invention relates to methods of treating an identified patient with a CDK7 inhibitor described herein, or a pharmaceutically acceptable salt thereof, either alone or in combination with a second therapeutic agent. In another aspect, the present invention features kits including instructions for treating a patient identified as described herein.
Patent WO-2022020883-A1 (WO)
Inventor: FARRER PETER
IPC: B33Y40/20
Filed: 2021-07-27
Abstract: A glove box machine for recovery of unfused powder from a build assembly removed from an SLM installation after completion of a build cycle, comprising a housing (12) with a volume defined by at two parts (22, 24) with a support device (32) adjustably mounted in relation to one housing part (22). The housing parts are relatively movable for the build assembly to be received within the volume and secured by a build plate (28) of the assembly on the support device. One housing part has at two glove ports with a fitted glove (40) whereby the hands of an operator can be inserted to perform within the housing tasks required for recovery of the unfused powder. The support device is movable to enable adjustment of the orientation of the build assembly to facilitate powder recovery from the build assembly.
Patent WO-2022036399-A1 (WO)
Title: Copper recovery method and apparatus
Inventor: HALLETT MICHAEL
IPC: F27D19/00
Filed: 2021-08-18
Abstract: An apparatus for recovering metal copper from a product material, comprising: a body having a central core formed therein and a coil mounted within the body and arranged to extend in a vertical axis so as to extend about the central core; a collecting crucible mounted beneath said core of the body for collecting metal copper from the product material; and a hoisting apparatus mounted with respect to the body, the hoisting apparatus being configured to lower the product material into the central core of the body and to suspend the product material therein; wherein, the coil is configured to receive a current to generate a magnetic field in the body such that the magnetic field generates eddy currents within the product material causing the product material to heat, thereby releasing the metal copper in a molten form from the product material into the collecting crucible for recovery.
Patent AU-2021200469-A1 (AU)
Title: System and method for transferring funds to and from a gaming establishment device
Inventor: SHEPHERD JEFFERY
IPC: G07F19/00
Filed: 2021-01-25
Abstract: IGT Matter No. P002286-001 NGE Matter No. 025094-8676 
ABSTRACT OF THE DISCLOSURE 
Systems and methods that account for a current balance of funds of a target device, such as a 
gaming establishment device, when determining whether or not to transfer an amount of funds 
between the target device and an account associated with the amount of funds.
Patent AU-2021201460-A1 (AU)
Title: Method for the manufacture of insoluble lead anodes, used in electrowinning or electro-refining processes of high purity
Inventor: MOUTHON HORACIO RAFART
IPC: C25C7/02
Filed: 2021-03-08
Abstract: A method for the manufacture of insoluble lead anodes, with low segregation of 
the constituent elements of the anodic alloy for the electrowinning of metals, free 
of buckling, used in electrolytic processes, which comprises: Obtaining a 
continuous plate (4) of lead or lead alloy 10 to 30 mm thick by 900 to 1,100 mm 
wide by means of a continuous casting process; Cut the continuous plate (4) 
according to a determined length obtaining a pre-plate (6) that will give the length 
of one or more plates of the anode (8); Roll the lead or lead alloy pre-plate (6) 
using a cold rolling mill (7) to a thickness of 6 to 12 mm, keeping the cold rolling 
temperature of the pre-plate under 60 0 C, obtaining the anode plate (s) (8); 
Remove the anode plate (8) from the rolling mill (7); Weld (12) a copper bar (10) 
to the upper end of the anode plate (11).
3/3 
t0 
12 
11 
Figure # 3
Patent AU-2021202115-A1 (AU)
Title: Systems and methods for managing accounting data
Inventor: NAGARAJ VEERACHETTIAR
IPC: G06Q40/00
Filed: 2021-04-06
Abstract: Technology disclosed herein relates to sensor-enabled mouthguards. Embodiments have 
been particularly developed to provide sensor-enabled mouthguards configured to enable 
monitoring of head impact data via multiple accelerometers, and data processing methods 
configured to analyse data derived from multiple accelerometers carried by a sensor
enabled mouthguard. This finds application, for example, in the context of managing brain 
injury risks in the context of sporting activities.
1/12 
101-1 101-2 101-n 
100 Accelerometer 1] erometer 1 
1 M N Accelerometerrn 
P pMemory Processor Comms 
102 103 L 104 105 
Example Mouthguard Device 
111 112 
130 PoerSupplyiMmor 110 
Further Mouthguard/ 113 
Secondary Transmitter Processor 
Hardware Sets E s 
Secondary Body-Worn Transmitter 
140 
121 122141 
120 Power Supply M y 
Pesso rCmm 
123 124 Display Screen 
Impact DataProcessing System 
0 
Exemplary Client Device 
FIG. 1
Patent AU-2021202206-A1 (AU)
Title: Flame retardant polyolefin articles
Inventor: LIPS GERARD
IPC: C08K5/3435
Filed: 2021-04-12
Abstract: The present invention relates to a flame-retardant article comprising a polyolefin substrate 
having additives incorporated therein, the additives comprising: 
a specific phosphonate ester of formula (1), 
a synergist comprising an N-alkoxy hindered amine, and 
a melamine cyanurate.  
The present invention also relates to corresponding flame retardant compositions, and the use 
of these for improving the flame retardency of polyolefins.  
17330864_1 (GHMatters) P107949.AU.1
Patent AU-2021202219-A1 (AU)
Title: Syringe stabilizer
Inventor: ARIAGNO SCOTT RICHARD
IPC: A61M5/00
Filed: 2021-04-13
Abstract: A syringe stabilizing apparatus (10) includes a base; and a syringe 
support disposed above the base. The syringe support includes a retainer 
having an opening configured to receive and retain a portion of an infusion set; 
and a selectively actuated tube clamp having a closed condition in which the 
selectively actuated tube clamp is configured to pinch a tubing of the infusion 
set closed, and the selectively actuated tube clamp having an open condition to 
allow a flow of fluid through the tubing.  
IAnrif ')1)
1/10 
50 46 
5044 g10 
106 
66 68 40 74 .54 
22 84 
58 
110 
FIG. 1 
18F72 
1098 - 7 
76 40 
22 84 
14 
FIG. 2
Patent AU-2021203089-A1 (AU)
Title: Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Inventor: PLETNEV ALEXANDER
IPC: C07K14/18
Filed: 2021-05-14
Abstract: of the Disclosure 
The present invention relates to attenuated, immunogenic West Nile virus 
chimeras built on a dengue virus backbone for the production of immunogenic, live, 
attenuated West Nile virus vaccines.
Patent AU-2021204211-A1 (AU)
Title: PD-1 / PD-L1 inhibitors for the treatment of cancer
Inventor: CUILLEROT JEAN-MARIE
IPC: C07K16/28
Filed: 2021-06-22
Abstract: The invention relates to methods of treating cancer in a subject, comprising 
administering to the subject a therapeutically effective amount of an inhibitor of the 
5 interaction between the PD-1 receptor and its ligand PD-1.
Patent AU-2021204454-A1 (AU)
Title: Methods and interfaces for home media control
Inventor: COFFMAN PATRICK L
IPC: H04L29/02
Filed: 2021-06-29
Abstract: The present disclosure generally relates to interfaces and techniques for media playback on 
one or more devices. In accordance with some embodiments, an electronic device includes a 
display, one or more processors, and memory. The electronic device receives user input and, 
in response to receiving the user input, displays, on the display, a multi-device interface that 
includes: one or more indicators associated with a plurality of available playback devices that 
are connected to the device and available to initiate play back of media from the device, and a 
media playback status of the plurality of available playback devices.
Patent AU-2021209244-A1 (AU)
Title: System And Method For Providing A Health Determination Service Based On User Knowledge And Activity
Inventor: JIAO SHUO
IPC: G09B7/04
Filed: 2021-07-28
Abstract: Examples are provided herein for providing a service in connection with 
determining a health of a user. A collection of questions are stored for the user, with 
each question being based on a documented assertion pertaining to human health.  
Each question in the collection of questions is associated with a correlative health 
parameter that is based at least in part on (i) persons in a control population that 
have independent knowledge of an assertion that is a basis of that question, and (ii) 
a value of a predetermined health parameter for each person in the control 
population, the value of the predetermined health parameter for each person being 
indicative of that person's health. Based on data generated by one or more activity 
monitoring devices, questions from the collection are selected for display to the user.
1/12 
Health and 
Users 11 Fitness 
Devices 191 
Network 101 
GE Response Analysis 
11 Device |164 
User Interface 110 Data Device DB Game1912 
UID Data 103 192 Scoring 
121 Gamification Layer 112 Profile 144 
Community Data_137 
Data 117 Data137Cred UID Community SN Layer 114 Score 
121 145 
1 A Qs 127a, 127b CD117 
Community User ID 121 Resp 131 
SN Service 116 Topic 123 Knowl. User Profile Question 
Session Info. 125 Level 138 Response 
s'nLeveIo135 135 Response Logic Data 118 
Question Selection I1 1 
120 Responses Knowledge Level 
129 Determ. 134 
Questions 
127a,127b Health Cor. Health Q. Rec 
Param. 133 
Value 151 Health Scoring ryQuestion14 
Param. 113 QId 
141rj Health Outcome 
Question Library 142 
152 Resp.143 Health 
Health 
Qs HealthParam. Health Outcome 
Question/ Values149 Outcome Score 
erif Analysis Sub- Definition 155 165 
np System 170 
L75 -models 172 Health Scoring Health 
Input Database Service 
Questions 150 190 
171 UserHealth 
Database 
160 
Control Population 
Database 180 
System 100 
FIG. 1
Patent AU-2021214174-A1 (AU)
Title: Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells
Inventor: PAKOLA STEPHEN JOSEPH
IPC: G01N33/66
Filed: 2021-01-28
Abstract: Compositions and methods are described for the delivery of recombinant human iduronate-2-sulfatase (IDS) produced by human neuronal or glial cells to the cerebrospinal fluid of the central nervous system (CNS) of a human subject diagnosed with mucopolysaccharidosis II (MPS II).
Patent AU-2021214417-A1 (AU)
Title: Drug delivery device
Inventor: SIDERIS ANDERS WILLIAM JAMES
IPC: A61L15/28
Filed: 2021-01-29
Abstract: A layered drug delivery device which includes a polymeric tissue interface layer and a polymeric backing layer. The polymeric tissue interface layer includes at least one ther-apeutic agent.
Patent AU-2021222390-A1 (AU)
Title: An outlet valve for an ostomy appliance
Inventor: HOLROYD SIMON
IPC: A61F5/445
Filed: 2021-02-18
Abstract: An outlet valve (1) for an ostomy appliance (30) comprises a valve base (10) for attachment to a face of the ostomy appliance (30), the valve base (10) defining a base opening (15) for receiving a liquid output from the ostomy appliance (30); and an outlet element (20) configured to be rotatable relative to the valve base (10) from a closed configuration in which discharge of the liquid received through the base opening (15) is prevented, to an open configuration in which discharge of the liquid received through the base opening (15) is enabled. The outlet element (20) comprises a relatively rigid component rotatably attached to the valve base (10) and a relatively flexible outlet tube portion (21a) affixed to the relatively rigid component.
Patent AU-2021254632-A1 (AU)
Title: Heat generating device and method for generating heat
Inventor: IWAMURA YASUHIRO
IPC: F24V30/00
Filed: 2021-10-22
Abstract: The present invention proposes a heat generating 
device and a method for generating heat capable of 
generating excess heat. The heat generating device 
configured such that a hydrogen-based gas is introduced 
into a container from a hydrogen-based gas introduction 
path, hydrogen is occluded in a heat generating element 5, 
and then the heat generating element 5 is heated with a 
heater and vacuuming is performed at the same time. Thus, 
the heat generating device is capable of generating 
excess heat equal to or higher than a heating temperature 
by allowing the hydrogen to permeate through a 
heterogeneous material interface 26 between a first layer 
23 and a second layer 24 in a manner of quantum diffusion.  
Thus, the heat generating device is capable of generating 
excess heat by allowing the hydrogen to permeate through 
the first layer 23 and the second layer 24 of a 
multilayer film 25.
Patent AU-2021260295-A1 (AU)
Title: Refrigerator door body
Inventor: WANG WENCHUN
IPC: H01H36/00
Filed: 2021-04-12
Abstract: The present invention provides a refrigerator door body, provided with a door liner and a storage device mounted on the door liner; a hanging lug and a fitting groove which fit each other are provided between the door liner and the storage device, a power supply module is provided, in a fitting manner, between the hanging lug and the fitting groove, the power supply module comprises a first connector provided on the hanging lug and a second connector provided at the fitting groove, and the first connector and the second connector are connected to each other in a fitting manner when the storage device is mounted. The refrigerator door body of the present invention not only can function to support the storage device, but also can function to supply power to the storage device.
Patent AU-2021283118-A1 (AU)
Title: Delayed release softgel capsules
Inventor: FANG QI
IPC: A23P10/30
Filed: 2021-06-01
Abstract: Delayed release softgel capsules comprise a fill material and a pH dependent shell composition, characterized in that the delayed release nature of the capsules may be achieved without a pH dependent coating or added conventional pH dependent polymers. The delayed release softgel capsules described herein are particularly suitable for initiating release of the active agent in a target location in the colon environment.
Patent AU-2021288045-A1 (AU)
Title: C-type natriuretic peptides and methods thereof in treating cancer
Inventor: TACHIBANA HIROFUMI
IPC: A61K38/17
Filed: 2021-06-11
Abstract: The present disclosure relates to methods of treating a subject having abnormal vasculature by administering to the subject a therapeutically effective bolus dose of a composition including a long acting C-type natriuretic peptide (CNP), CNP derivative, long acting CNP derivative, long acting CNP receptor (NPRB) agonist, or any combination thereof. The present disclosure further relates to treating a subject in need of an increase in cytotoxic T cell and/or NK cell activity by administering to the subject a therapeutically effective bolus dose of a composition including a long acting C-type natriuretic peptide (CNP), CNP derivative, long acting CNP derivative, long acting CNP receptor (NPRB) agonist, or any combination thereof.
Patent AU-2021294796-A1 (AU)
Title: Salt of compound and pharmaceutical composition containing salt
Inventor: ZHU CHENGGANG
IPC: A61K31/53
Filed: 2021-06-23
Abstract: The present invention relates to a salt formed by a compound of formula (I) and an acid. The acid is selected from hydrochloric acid, methanesulfonic acid, benzenesulfonic acid, ethanesulfonic acid, maleic acid, hydrobromic acid, citric acid, L-tartaric acid, and p-toluenesulfonic acid. The present invention also relates to a method for treating non-small cell lung cancer (NSCLC) with an EGFR exon 20 insertion mutation by means of using the salt.
Patent AU-2021308077-A1 (AU)
Title: Particulates of polyphenolics and dispersions thereof
Inventor: SARKAS HARRY W
IPC: A61K8/02
Filed: 2021-07-16
Abstract: A composition includes polyphenolic particles and a surfactant, on the polyphenolic particles. The composition is lipophilic. The polyphenolic particles are non-pigmentary. A dispersion includes the polyphenolic particles, the surfactant, and a carrier vehicle. The carrier vehicle may be a cosmetically-acceptable fluid or a wax that is lipophilic.
Patent AU-2021313137-A1 (AU)
Title: A system and method for developing an alternative drug therapy using characteristics of an existing drug therapy to produce a similar pathway behavior
Inventor: JALLI INDERPREET
IPC: A61B5/00
Filed: 2021-07-19
Abstract: A method for developing a new drug therapy using characteristics of an existing drug therapy, the method comprising the following steps: developing a new-treatment mathematical model of a targeted biological network and synthesizing a drug therapy based on the new-treatment mathematical model. The new treatment mathematical model can be capable of producing a new- treatment time-course progression comprising a time-course progression signature found in an existing-treatment time-course progression of an existing treatment mathematical model of the targeted biological network. The time-course progression signature can be related to an outcome of said targeted biological network. A drug regimen can be synthesized for each the new treatment intervention constant, and the drug regimens together can be a new drug therapy.
Patent AU-2021338837-A1 (AU)
Title: Methods of treating PDE IV mediated diseases or conditions
Inventor: KOPRIVICA VUK
IPC: A61K31/53
Filed: 2021-09-10
Abstract: The disclosure provides methods and compositions for the treatment of PDE IV-mediated diseases or conditions, including inflammatory diseases or conditions, using a compound of Formula (I) or a pharmaceutically acceptable salt thereof:
Patent AU-2021394536-A1 (AU)
Title: Composition
Inventor: BATCHELOR STEPHEN
IPC: C11D3/386
Filed: 2021-11-26
Abstract: A liquid laundry detergent composition comprising C16 and C18 alcohol ethoxylate surfactant wherein the C18 alcohol ethoxylate comprises monounsaturated C18, wherein the proportion of monounsaturated C18 constitutes at least 50% wt. of the total C16 and C18 alcohol ethoxylate surfactant and wherein the C16 alcohol ethoxylate comprises at least 4% of the total C16 and C18 alcohol ethoxylate surfactant and wherein the C16 and 18 alcohol ethoxylate has an average of from 8 to 20 EO groups.